Back
CRISPR Therapeutics AG Vs. NLS Pharmaceutics Industry Stock Comparison
Buy
69
CRSP
CRISPR Therapeutics AG
Last Price:
50.39
Seasonality Move:
24.62%
Sell
20
NLSP
NLS Pharmaceutics
Last Price:
4.04
Seasonality Move:
25.8%
Buy
69
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $50.62. The Score for CRSP is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- CRSP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $4.39. The Score for NLSP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $50.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $4.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight buying pressure.
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 58.87 | Buy |
| Chaikin Money Flow: | 67308 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.6 - 49.02) | Buy |
| Bollinger Bands (100): | (45.71 - 56.19) | Sell |
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 46.17 | Sell |
| Chaikin Money Flow: | 4293203 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.12 - 5.12) | Sell |
| Bollinger Bands (100): | (4.83 - 7.99) | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.71 | Buy |
| 20-day SMA: | 47.71 | Buy |
| 50-day SMA: | 47.22 | Buy |
| 200-day SMA: | 58.2 | Sell |
| 8-day EMA: | 48.91 | Buy |
| 20-day EMA: | 48.1 | Buy |
| 50-day EMA: | 48.33 | Buy |
| 200-day EMA: | 53.88 | Sell |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.02 | Buy |
| 20-day SMA: | 4.52 | Sell |
| 50-day SMA: | 5.11 | Sell |
| 200-day SMA: | 8.36 | Sell |
| 8-day EMA: | 4.11 | Buy |
| 20-day EMA: | 4.45 | Sell |
| 50-day EMA: | 5.16 | Sell |
| 200-day EMA: | 10.1 | Sell |
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.69 per share, and an increase next year of $0.35 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NLS Pharmaceutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||